ROBIN BROWN: Open Payments
NPI 1801445903 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,837 in 32 payments from 10 companies in 2025. Trend: 2023 $1,191 · 2024 $749 · 2025 $1,837
Food & beverage: $1,011Travel & lodging: $826
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 11 | $1,384 |
| Merck Sharp & Dohme LLC | 5 | $122 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| PFIZER INC. | 2 | $51 |
| Boston Scientific Corporation | 2 | $50 |
| BridgeBio Pharma, Inc. | 2 | $46 |
| Novo Nordisk Inc | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| Impulse Dynamics (USA) Inc. | 1 | $31 |
| SCPHARMACEUTICALS INC. | 1 | $17 |
Products named: Barostim Neo System, VERQUVO, FARXIGA, VYNDAQEL, Attruby, Wegovy, LEQVIO, WATCHMAN FLX.
Industry payments across GA — which companies pay providers there.
